CTLA4 and neoplasm: First, inhibition of CTLA-4 enhances early activation and proliferation of effector T cells upon tumor neoantigen recognition in the lymph nodes (Rooij et al. 2013; Snyder et al. 2014; Ribas and Wolchok 2018).